Literature DB >> 17461479

Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats.

Xi Jin1, Chao-Hui Yu, Guo-Cai Lv, You-Ming Li.   

Abstract

AIM: To investigate whether increased intestinal permeability contributes to the pathogenesis and progress of nonalcoholic steatohepatitis by observing its dynamic change in rat models.
METHODS: Rat models of nonalcoholic steatohepatitis were established by giving a fat-rich diet. The rats were sacrificed at wk 8, 12 and 16 during the study. Rats fed with normal diet were taken as control. Plasma D-lactate, plasma diamine oxidase, serum lipids and liver transaminases were measured in blood of the femoral artery. Hepatic steatosis and inflammation were assessed by haematoxylin-eosin staining.
RESULTS: A rat model of nonalcoholic steatohepatitis was established successfully. Plasma D-lactate level in model group at wk 8, 12 and 16 and diamine oxidase level in model group at wk 12, 16 increased significantly compared with those in control group. There were notable differences of D-lactate and diamine oxidase level in model group between wk 8 and 12 as well as between wk 12 and 16. Serum lipids, liver transaminases and liver injury also increased with disease development.
CONCLUSION: Increased intestinal permeability caused by intestinal bacterial overgrowth and endotoxin-induced intestinal destruction exists in rats with nonalcoholic steatohepatitis, which may partially explain the pathogenesis and progress of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17461479      PMCID: PMC4146955          DOI: 10.3748/wjg.v13.i11.1732

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis.

Authors:  S M Riordan; V M Duncombe; M C Thomas; A Nagree; T D Bolin; C J McIver; R Williams
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  Spectrophotometric assay for D-(-)-lactate in plasma.

Authors:  R B Brandt; S A Siegel; M G Waters; M H Bloch
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

4.  Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

Authors:  A Parlesak; C Schäfer; T Schütz; J C Bode; C Bode
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

5.  Intestinal permeability in liver cirrhosis.

Authors:  G Ersöz; A Aydin; S Erdem; D Yüksel; U Akarca; K Kumanlioglu
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-04       Impact factor: 2.566

6.  The leaky gut of alcoholism: possible route of entry for toxic compounds.

Authors:  I Bjarnason; T J Peters; R J Wise
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

7.  Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.

Authors:  Peng Ruan; Zuo-Jiong Gong; Quan-Rong Zhang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-02

8.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

9.  In vitro expression of CD14 protein and its gene in Kupffer cells induced by lipopolysaccharide.

Authors:  Xu-Hong Li; Jian-Ping Gong; Yu-Jun Shi; Chang-An Liu; Yong Peng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-11

10.  Intestinal permeability and absorptive capacity in children with portal hypertension.

Authors:  R M Taylor; I Bjarnason; P Cheeseman; M Davenport; A J Baker; G Mieli-Vergani; A Dhawan
Journal:  Scand J Gastroenterol       Date:  2002-07       Impact factor: 2.423

View more
  13 in total

1.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

2.  Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis.

Authors:  Zhenlong Luo; Yudong Ji; Dinghong Zhang; Hong Gao; Zhongmou Jin; Meixiang Yang; Wei Ying
Journal:  Acta Physiol (Oxf)       Date:  2022-05-10       Impact factor: 7.523

3.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

Review 4.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

Review 5.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

6.  Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.

Authors:  Ren-Ying Xu; Yan-Ping Wan; Qi-Yu Fang; Wei Lu; Wei Cai
Journal:  J Clin Biochem Nutr       Date:  2011-08-24       Impact factor: 3.114

7.  Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway.

Authors:  Sufang Chen; Xiang Li; Yanling Wang; Panwei Mu; Chaojin Chen; Pinjie Huang; Dezhao Liu
Journal:  Mol Med Rep       Date:  2019-03-12       Impact factor: 2.952

8.  CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance.

Authors:  Zhenlong Luo; Yudong Ji; Hong Gao; Felipe Castellani Gomes Dos Reis; Gautam Bandyopadhyay; Zhongmou Jin; Crystal Ly; Ya-Ju Chang; Dinghong Zhang; Deepak Kumar; Wei Ying
Journal:  Gastroenterology       Date:  2020-11-02       Impact factor: 22.682

9.  Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice.

Authors:  Hong Gao; Zhongmou Jin; Kechun Tang; Yudong Ji; Jorge Suarez; Jorge A Suarez; Karina Cunha E Rocha; Dinghong Zhang; Wolfgang H Dillmann; Sushil K Mahata; Wei Ying
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

10.  Does increased serum d-lactate mean subclinical hyperpermeability of intestinal barrier in middle-aged nonobese males with OSA?

Authors:  Mulalibike Heizati; Nanfang Li; Liang Shao; Xiaoguang Yao; Yingchun Wang; Jing Hong; Ling Zhou; Delian Zhang; Guijuan Chang; Suofeiya Abulikemu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.